Health Condition 1: B379- Candidiasis, unspecified
Conditions
Interventions
Intervention1: NIL: NA
Control Intervention1: NIL: NA
Sponsors
Datta Meghe Institute of Higher Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: All clinically relevant isolates of Non-albicans candida species that will be isolates from specimens received from February 2024 to August 2026 in the department of microbiology Tertiary health care centre.
Exclusion criteria
Exclusion criteria: Samples which shows the growth of Candida albicans will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Isolation of Candida species, Antifungal sensitivity pattern for Azoles among Non-albicans candida species isolates by Disc diffusion method,Timepoint: At the end of 24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Antifungal sensitivity test for fluconazole among Non-albicans candida species by Micro broth dilution method and studying mutations in ERG11 gene.Timepoint: At the end of 24 months | — |
Countries
India
Contacts
Public ContactDr Deependra Manish
Datta Meghe Institute of Higher Education and Research
Outcome results
None listed